Pacira Biosciences, Inc. (PCRX)
24.76
-0.29
(-1.16%)
USD |
NASDAQ |
Oct 06, 16:00
24.76
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Price to Book Value : 1.467 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.467 |
| October 05, 2026 | 1.484 |
| October 02, 2026 | 1.494 |
| October 01, 2026 | 1.482 |
| September 30, 2026 | 1.484 |
| September 29, 2026 | 1.520 |
| September 28, 2026 | 1.505 |
| September 25, 2026 | 1.489 |
| September 24, 2026 | 1.515 |
| September 23, 2026 | 1.460 |
| September 22, 2026 | 1.464 |
| September 21, 2026 | 1.429 |
| September 18, 2026 | 1.463 |
| September 17, 2026 | 1.451 |
| September 16, 2026 | 1.476 |
| September 15, 2026 | 1.427 |
| September 14, 2026 | 1.463 |
| September 11, 2026 | 1.503 |
| September 10, 2026 | 1.491 |
| September 09, 2026 | 1.534 |
| September 08, 2026 | 1.533 |
| September 04, 2026 | 1.562 |
| September 03, 2026 | 1.576 |
| September 02, 2026 | 1.575 |
| September 01, 2026 | 1.569 |
| Date | Value |
|---|---|
| August 31, 2026 | 1.535 |
| August 28, 2026 | 1.527 |
| August 27, 2026 | 1.531 |
| August 26, 2026 | 1.535 |
| August 25, 2026 | 1.513 |
| August 24, 2026 | 1.473 |
| August 21, 2026 | 1.462 |
| August 20, 2026 | 1.412 |
| August 19, 2026 | 1.444 |
| August 18, 2026 | 1.422 |
| August 17, 2026 | 1.377 |
| August 14, 2026 | 1.363 |
| August 13, 2026 | 1.374 |
| August 12, 2026 | 1.404 |
| August 11, 2026 | 1.445 |
| August 10, 2026 | 1.448 |
| August 07, 2026 | 1.483 |
| August 06, 2026 | 1.516 |
| August 05, 2026 | 1.474 |
| August 04, 2026 | 1.637 |
| August 03, 2026 | 1.595 |
| July 31, 2026 | 1.565 |
| July 30, 2026 | 1.598 |
| July 29, 2026 | 1.564 |
| July 28, 2026 | 1.589 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.221 |
| Liquidia Corp. | 11.83 |
| ANI Pharmaceuticals, Inc. | 2.751 |
| Corcept Therapeutics, Inc. | 18.28 |
| Veru, Inc. | 1.484 |
Price to Book Value Related Metrics
| PE Ratio | 71.33 |
| PS Ratio | 1.399 |
| Price to Free Cash Flow | 5.815 |
| Price | 24.76 |
| Earnings Yield | 1.40% |
| Market Cap | 986.00M |
| Operating PE Ratio | 37.78 |
| Normalized PE Ratio | 50.82 |